TB-500: The Cell Protein That Keeps Spare Scaffolding Ready

Every cell in your body has a skeleton inside it. It is made of thin threads of a protein called actin. Picture scaffolding poles that the cell builds and takes apart all day long.

To move or heal, a cell needs spare poles ready to go. A small protein keeps that pile in order. Its name is thymosin beta-4, and it is the science behind TB-500.

What it is

A peptide is a short chain of amino acids. Think of amino acids as beads and a peptide as a bead bracelet. New here? Start with what a peptide is.

Thymosin beta-4 is a chain of 43 beads. That is long for a bracelet, so scientists often call it a small protein.

Nearly every cell in your body makes it. It also turns up in body fluids.

TB-500 is a lab-made piece of thymosin beta-4. It is just 7 beads long: the part of the chain that grabs actin. People often mention it next to BPC-157, another repair peptide under study.

Keep in mind that the studies below used the full 43-bead protein, not the 7-bead piece.

What it does in the body

Actin comes in two forms: single beads and long threads. Thymosin beta-4 holds on to the single beads. A bead it holds cannot join a thread.

That sounds like a brake, but it is really a storeroom. The cell keeps a big stock of spare beads on hand. When it needs to move or close a wound, the parts are ready.

Thymosin beta-4 does more than hold actin. It can team up with other proteins inside the cell. One such team switches on a survival signal that helps cells stay alive.

Scientists have found it outside cells too. There it may act as a signal to nearby cells. That is why it has been studied in wounds, eyes and the heart.

What scientists have found

In cells: In a 1999 study, skin cells in a dish moved toward thymosin beta-4. A tiny amount made them move two to three times more within five hours.

In a 2004 study, heart muscle cells in a dish moved more, and more of them survived. Thymosin beta-4 had joined with two partner proteins to switch on the survival signal.

In animals: In rats with deep skin wounds, treated wounds grew 42% more new skin cover by day 4. By day 7, the gain was as much as 61%. Treated wounds also had more collagen, the skin's scaffolding, and more new blood vessels.

In mice with a chemical burn on the eye, drops of thymosin beta-4 helped the surface re-cover faster. By day 7, the eyes also had fewer inflammatory cells, the white cells that rush to an injury.

In the 2004 mouse study, scientists blocked a heart artery to mimic a heart attack. Mice given thymosin beta-4 kept more heart cells alive early on. Their hearts also pumped better afterward.

In people: In a 2010 study, 40 healthy volunteers got thymosin beta-4 or a placebo by vein. A placebo is a dummy look-alike. Side effects were few and mild or moderate. None were serious.

In a 2015 trial, 72 people with dry eye used thymosin beta-4 drops or placebo drops for 28 days. On the two main measures, the groups did not differ. On some other measures, the drops did better. Eye discomfort in a dry-air room was 27% lower. No side effects were reported.

Where it stands

TB-500 is not an ingredient in any FDA-approved medicine. In 2026, FDA staff reviewed it for an advisory committee and found no clinical studies of TB-500 itself. Thymosin beta-4 is still in trials. The World Anti-Doping Agency bans thymosin beta-4 and TB-500 in sport at all times.

Researchers want to know if the eye results hold up in bigger trials. They also hope to test the heart findings in people with heart disease. And they want studies on the 7-bead piece itself.

It is early days, and thymosin beta-4 is one to watch.

The bottom line

• Thymosin beta-4 is a 43-amino-acid protein that nearly all your cells make. It holds spare actin beads, the parts of the cell's scaffolding.
• In rats and mice, skin and eye wounds closed faster, and injured hearts pumped better.
• In people, early trials found few side effects. The exciting next step is bigger studies, and tests of TB-500 itself.